Journal article
Assessment of DNA methylation profiling and copy number variation as indications of clonal relationship in ipsilateral and contralateral breast cancers to distinguish recurrent breast cancer from a second primary tumour
KT Huang, T Mikeska, J Li, EA Takano, EKA Millar, PH Graham, SE Boyle, IG Campbell, TP Speed, A Dobrovic, SB Fox
BMC Cancer | Published : 2015
Abstract
Background: Patients with breast cancer have an increased risk of developing subsequent breast cancers. It is important to distinguish whether these tumours are de novo or recurrences of the primary tumour in order to guide the appropriate therapy. Our aim was to investigate the use of DNA methylation profiling and array comparative genomic hybridization (aCGH) to determine whether the second tumour is clonally related to the first tumour. Methods: Methylation-sensitive high-resolution melting was used to screen promoter methylation in a panel of 13 genes reported as methylated in breast cancer (RASSF1A, TWIST1, APC, WIF1, MGMT, MAL, CDH13, RARβ, BRCA1, CDH1, CDKN2A, TP73, and GSTP1) in 29 t..
View full abstractGrants
Funding Acknowledgements
We wish to thank members of the Molecular Pathology Research and Development group in Peter MacCallum Cancer Centre for their help and support. We would like to thank Dr. Christoph Bock for helpful comments on analysis of the methylation results. This work was funded by grants from the Victorian Breast Cancer Research Consortium, Cancer Australia, the National Breast Cancer Foundation of Australia (Collaborative Research Program) and the Cancer Council of Victoria.